A detailed history of Principal Financial Group Inc transactions in Natera, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 1,012,498 shares of NTRA stock, worth $169 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,012,498
Previous 983,747 2.92%
Holding current value
$169 Million
Previous $107 Million 20.8%
% of portfolio
0.07%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$97.75 - $129.67 $2.81 Million - $3.73 Million
28,751 Added 2.92%
1,012,498 $129 Million
Q2 2024

Jul 29, 2024

SELL
$85.28 - $112.6 $33.5 Million - $44.2 Million
-392,666 Reduced 28.53%
983,747 $107 Million
Q1 2024

Apr 29, 2024

SELL
$59.21 - $92.9 $19.4 Million - $30.4 Million
-327,202 Reduced 19.21%
1,376,413 $126 Million
Q4 2023

Feb 07, 2024

BUY
$37.55 - $62.64 $4.24 Million - $7.07 Million
112,825 Added 7.09%
1,703,615 $107 Million
Q3 2023

Nov 02, 2023

BUY
$43.4 - $62.52 $5.22 Million - $7.52 Million
120,225 Added 8.18%
1,590,790 $70.4 Million
Q2 2023

Aug 07, 2023

SELL
$47.08 - $55.16 $19.9 Million - $23.3 Million
-422,743 Reduced 22.33%
1,470,565 $71.6 Million
Q1 2023

May 09, 2023

SELL
$36.57 - $58.29 $4.19 Million - $6.68 Million
-114,552 Reduced 5.71%
1,893,308 $105 Million
Q4 2022

Feb 09, 2023

BUY
$34.17 - $47.91 $29.6 Million - $41.5 Million
867,205 Added 76.03%
2,007,860 $80.7 Million
Q3 2022

Nov 09, 2022

BUY
$36.93 - $56.68 $4.18 Million - $6.41 Million
113,175 Added 11.01%
1,140,655 $50 Million
Q2 2022

Aug 10, 2022

BUY
$28.13 - $44.54 $7.58 Million - $12 Million
269,608 Added 35.57%
1,027,480 $36.4 Million
Q1 2022

May 09, 2022

SELL
$30.32 - $91.33 $1.77 Million - $5.34 Million
-58,434 Reduced 7.16%
757,872 $30.8 Million
Q4 2021

Feb 09, 2022

BUY
$86.26 - $119.0 $8.99 Million - $12.4 Million
104,181 Added 14.63%
816,306 $76.2 Million
Q3 2021

Nov 09, 2021

SELL
$100.17 - $126.36 $2.44 Million - $3.08 Million
-24,346 Reduced 3.31%
712,125 $79.4 Million
Q2 2021

Aug 10, 2021

BUY
$86.05 - $119.72 $319,331 - $444,280
3,711 Added 0.51%
736,471 $83.6 Million
Q1 2021

May 10, 2021

BUY
$91.47 - $124.36 $20.7 Million - $28.1 Million
226,216 Added 44.66%
732,760 $74.4 Million
Q4 2020

Feb 08, 2021

SELL
$66.66 - $111.74 $2.76 Million - $4.63 Million
-41,422 Reduced 7.56%
506,544 $50.4 Million
Q3 2020

Nov 06, 2020

SELL
$45.89 - $72.67 $3.24 Million - $5.13 Million
-70,553 Reduced 11.41%
547,966 $39.6 Million
Q2 2020

Aug 05, 2020

BUY
$26.36 - $49.86 $5.92 Million - $11.2 Million
224,622 Added 57.03%
618,519 $30.8 Million
Q1 2020

May 12, 2020

SELL
$17.27 - $40.17 $150,767 - $350,684
-8,730 Reduced 2.17%
393,897 $11.8 Million
Q4 2019

Feb 05, 2020

BUY
$32.1 - $40.4 $2.06 Million - $2.59 Million
64,205 Added 18.97%
402,627 $13.6 Million
Q3 2019

Nov 13, 2019

BUY
$25.38 - $34.89 $2.12 Million - $2.91 Million
83,448 Added 32.73%
338,422 $11.1 Million
Q2 2019

Aug 12, 2019

BUY
$17.75 - $27.58 $27,654 - $42,969
1,558 Added 0.61%
254,974 $7.03 Million
Q1 2019

May 10, 2019

BUY
$11.34 - $20.62 $229,192 - $416,750
20,211 Added 8.67%
253,416 $5.23 Million
Q4 2018

Feb 14, 2019

BUY
$12.32 - $24.38 $1.08 Million - $2.14 Million
87,750 Added 60.33%
233,205 $3.26 Million
Q3 2018

Nov 14, 2018

SELL
$18.82 - $28.96 $42,363 - $65,188
-2,251 Reduced 1.52%
145,455 $3.48 Million
Q2 2018

Aug 13, 2018

SELL
$8.79 - $19.98 $7,893 - $17,942
-898 Reduced 0.6%
147,706 $0
Q1 2018

May 14, 2018

SELL
$9.0 - $11.95 $64,386 - $85,490
-7,154 Reduced 4.59%
148,604 $1.38 Million
Q4 2017

Feb 13, 2018

SELL
$8.99 - $14.31 $115,278 - $183,497
-12,823 Reduced 7.61%
155,758 $1.4 Million
Q3 2017

Nov 02, 2017

BUY
$8.02 - $13.33 $1.35 Million - $2.25 Million
168,581
168,581 $2.17 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.